Antibody and immune memory persistence post infant hepatitis B vaccination

Patient Preference and Adherence

Volumn 7, Issue , 2013, Pages 981-986

  Hudu, Shuaibu A ^a,b   Malik, Yasmin A ^c   Niazlin, Mohd Taib ^a   Harmal, Nabil S ^a,d   Adnan, Ariza ^e   Alshrari, Ahmed S ^a   Sekawi, Zamberi ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b USMANU DANFODIYO UNIVERSITY   (Nigeria)

^c UNIVERSITI TUNKU ABDUL RAHMAN   (Malaysia)

^d SANA A UNIVERSITY   (Yemen)

^e Sungai Buloh   (Malaysia)

Author keywords

Anamnestic response; Booster vaccination; Hepatitis B vaccination; Persistent immunity

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; RECOMBINANT HEPATITIS B VACCINE;

ANTIBODY RESPONSE; ANTIBODY SCREENING; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HEPATITIS B; HUMAN; IMMUNOLOGICAL MEMORY; MALE; ONSET AGE; SINGLE DRUG DOSE; TREATMENT DURATION; UNDERGRADUATE STUDENT; VACCINATION; VIRUS IMMUNITY; VOLUNTEER;

EID: 84885194391     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S49776     Document Type: Article

References (34)

1. Howard CR, Allison LM. Hepatitis B surface antigen variation and protective immunity. Intervirology. 1995;38(1-2):35-40.
2. Waters JA, O'Rourke SM, Richardson SC, Papaevangelou G, Thomas HC. Qualitative analysis of the humoral immune response to the a determinant of HBs antigen after inoculation with plasma-derived or recombinant vaccine. J Med Virol. 1987;21(2):155-160.
3. Tong S, Kim KH, Chante C, Wands J, Li J. Hepatitis B Virus e Antigen Variants. Int J Med Sci. 2005;2(1):2-7.
4. Halliday ML, Rankin JG, Bristow NJ, Coates RA, Corey PJ, Strickler AC. A randomized double-blind clinical trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine compared with a plasma-derived vaccine. Arch Intern Med. 1990;150(6):1195-1200.
5. Banatvala J, Van Damme P, Oehen S. Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory. Vaccine. 2000;19(7-8):877-885.
6. van Montfoort N, Mangsbo SM, Camps MG, et al. Circulating specific antibodies enhance systemic cross-priming by delivery of complexed antigen to dendritic cells in vivo. Eur J Immunol. 2012;42(3): 598-606.
7. Honorati MC, Facchini A. Immune response against HBsAg vaccine. World J Gastroenterol. 1998;4(6):464-466.
8. Merican I, Guan R, Amarapuka D, et al. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol. 2000;15(12): 1356-1361.
9. Ng KP, Saw TL, Baki A, Rozainah K, Pang KW, Ramanathan M. Impact of the Expanded Program of Immunization against hepatitis B infection in school children in Malaysia. Med Microbiol Immunol. 2005;194(3): 163-168.
10. Szmuness W, Stevens CE, Zang EA, Harley EJ, Kellner A. A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology. 1981;1(5):377-385.
11. Poovorawan Y, Chongsrisawat V, Theamboonlers A, Leroux-Roels G, Crasta PD, Hardt K. Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers. Hum Vaccin Immunother. 2012;8(7): 896-904.
12. Hammitt LL, Hennessy TW, Fiore AE, et al. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years. Vaccine. 2007;25(39-40): 6958-6964.
13. But DY, Lai CL, Lim WL, Fung J, Wong DK, Yuen MF. Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: Final report. Vaccine. 2008;26(51): 6587-6591.
14. Yates TA, Paranthaman K, Yu LM, et al. UK vaccination schedule: persistence of immunity to hepatitis B in children vaccinated after perinatal exposure. Arch Dis Child. 2013;98(6):429-433.
15. Fiore TAE, Negus S, et al. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy. Pediatrics. 2007;120(2):e373-e381.
16. Bialek SR, Bower WA, Novak R, et al. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study. Pediatr Infect Dis J. 2008;27(10):881-885.
17. Lao TT, Sahota DS, Suen SS, Chan PK, Leung TY. Impact of neonatal hepatitis B vaccination programme on age-specific prevalence of hepatitis B infection in teenage mothers in Hong Kong. Epidemiol Infect. 2012:1-9.
18. Alexandre KV, Martins RM, Souza MM, Rodrigues IM, Teles SA. Brazilian hepatitis B vaccine: a six-year follow-up in adolescents. Mem Inst Oswaldo Cruz. 2012;107(8):1060-1063.
19. Jafarzadeh A, Montazerifar SJ. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth. J Ayub Med Coll Abbottabad. 2006;18(4):4-9.
20. Samandari T, Fiore AE, Negus S, et al. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy. Pediatrics. 2007;120(2):e373-e381.
21. Lu CY, Chiang BL, Chi WK, et al. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology. 2004;40(6):1415-1420.
22. Chaves SS, Groeger J, Helgenberger L, et al. Improved anamnestic response among adolescents boosted with a higher dose of the hepatitis B vaccine. Vaccine. 2010;28(16):2860-2864.
23. Leuridan E, Van Damme P. Hepatitis B and the need for a booster dose. Clin Infect Dis. 2011;53(1):68-75.
24. Chaves SS, Fischer G, Groeger J, et al. Persistence of long-term immunity to hepatitis B among adolescents immunized at birth. Vaccine. 2012;30(9):1644-1649.
25. Ahad MA, Alim MA, Guho A, Islam QT, Azad KAK. Role of Booster Dose on Antibody Titer after Recombinant Hepatitis B Vaccination. Journal of Medicine. 2009;10(2):67-76.
26. Barash C, Conn MI, DiMarino AJ, Marzano J, Allen ML. Serologic hepatitis B immunity in vaccinated health care workers. Arch Intern Med. 1999;159(13):1481-1483.
27. Zeeshan M, Jabeen K, Ali AN, et al. Evaluation of immune response to Hepatitis B vaccine in health care workers at a tertiary care hospital in Pakistan: an observational prospective study. BMC Infect Dis. 2007;7:120.
28. No author listed. Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity. Lancet. 2000;355(9203):561-565.
29. De Paschale M, Manco MT, Belvisi L, et al. Prevalence of markers of hepatitis B virus infection or vaccination in HBsAg-negative subjects. Blood Transfus. 2012;10(3):344-350.
30. Wu Q, Zhuang GH, Wang XL, Wang LR, Li N, Zhang M. Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: results of a randomized placebo-controlled trial cohort from China where endemicity is high. Vaccine. 2011;29(12): 2302-2307.
31. Mendy M, Peterson I, Hossin S, et al. Observational study of vaccine efficacy 24 years after the start of hepatitis B vaccination in two Gambian villages: no need for a booster dose. PLoS ONE. 2013;8(3): e58029.
32. Su FH, Bai CH, Chu FY, Lin YS, Su CT, Yeh CC. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan. Vaccine. 2012;30(27):4034-4039.
33. Bay CE. California Association for Medical Laboratory Technology. 2012. Available from: http://www.camlt.org/pdf_files/forms/004-form.pdf.
34. Pondé RA. A typical serological profiles in hepatitis B virus infection. Eur J Clin Microbiol Infect Dis. 2013;32(4):461-476. Available from: http://link.springer.com/article/10.1007/s10096-012-1781-9.